共 50 条
- [1] A new class of selective inhibitors of the p110-alpha isoform of PI3K as cancer drugs[J]. CANCER RESEARCH, 2009, 69Denny, WilliamKendall, JackieRewcastle, GordonShepherd, PeterFlanagan, JackBaguley, BruceKestell, PhilGiddens, AnnaTsang, SophiaMarshall, Andrew
- [2] Discovery and optimization of pyrimidone PI3Kβ inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245Halley, Frank
- [3] Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure[J]. MOLECULES, 2022, 27 (19):Jia, WenqingLuo, ShuyuZhao, WennanXu, WeirenZhong, YuxuKong, Dexin
- [4] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948Jia, HongDai, GuangxiuSu, WeiguoXiao, KunWeng, JianyangZhang, ZhulinWang, QingYuan, TianhaiShi, FuyingZhang, ZhengChen, WeiSai, YangWang, JianLi, XiongCai, YuYu, JunRen, PingVenable, JenniferRao, TadimetiEdwards, James P.Bembenek, Scott D.
- [5] Discovery of novel class of alpha selective PI3K inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254Garland, KeiraHanan, EmilyStaben, StevenBraun, Marie-GabrielleEdgar, KyleEndres, NickFriedman, LoriNguyen, AmandaPang, JodiePurkey, HansSalphati, LaurentSchmidt, StephenSong, KyungUltsch, MarkJaochico, AllanChan, ConnieEigenbrot, CharlesMacLeod, CalumJackson, PhilipNarukulla, RamanKnight, JamieYeap, KuenMessick, KristenValle, NicoleHeald, RobertNannini, MichelleHamilton, PatClausen, SaundraYoung, AmySampath, DeepakHong, RebeccaLee, Man-LingBlench, TobyElliott, RichardLu, AijunGu, Xiao-HuXin, Jianfeng
- [6] Motility of human colorectal cancer cells is promoted by H1047R kinase mutation of PI3K p110-alpha[J]. CANCER RESEARCH, 2012, 72Wan, GuanghuaOngchin, MelanieHand, EssenceRajput, Ashwani
- [7] Discovery of novel and highly selective PI3Kδ inhibitors based on the p110δ crystal structure[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (08): : 2499 - 2508Jia, Wen-QingLiu, Ya-YaFeng, Xiao-YanXu, Wei-RenCheng, Xian-Chao
- [8] Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208Teng, YuLi, XinyuRen, ShengnanCheng, YuXi, KunShen, HongtaoMa, WenzhuoLuo, GuoshunXiang, Hua
- [9] Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (09): : 936 - 940Safina, Brian S.Elliott, Richard L.Forrest, Andrew K.Heald, Robert A.Murray, Jeremy M.Nonomiya, JimPang, JodieSalphati, LaurentSeward, Eileen M.Staben, Steven T.Ultsch, MarkWei, BinqingYang, WenqianSutherlin, Daniel P.
- [10] Discovery and optimization of a series of benzothiazole PI3K/mTOR dual inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242D'Angelo, Noel D.Kim, Tae-SeongAndrews, KristinBooker, Shon K.Caenepeel, SeanChen, KuiD'Amico, DerinFreeman, DanJiang, JianLiu, LongbinMcCarter, John D.Miguel, Tisha SanMullady, Erin L.Schrag, MichaelSubramanian, RajuTang, JinWahl, Robert C.Wang, LingWhittington, Douglas A.Wu, TianXi, NingXu, YangYakowec, PeterYang, KevinZalameda, Leeanne P.Zhang, NancyHughes, PaulNorman, Mark H.